CBPO News and Press, China Biologic Products Holdings Inc. From 03/13/20

Image source: The Motley Fool. China Biologic Products Inc   (NASDAQ: CBPO) Q4 2019 Earnings Call Mar 13, 2020 , 7:30 a.m. ET Operator Continue reading

China Biologic Products Holdings, Inc. (CBPO) Q4 2019 Earnings Conference Call March 13, 2020, 07:30 ET Company Participants Samuel Martin - IR Joseph Chow - Chairman & CEO Ming Yang - CFO Conference Call Participants Presentation Operator Hello, and welcome to ...

China Biologic Products (NASDAQ: CBPO ): Q4 Non-GAAP EPS of $0.53; GAAP EPS of $0.32. More news on: China Biologic Products Holdings, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...

BEIJING , March 12, 2020 /PRNewswire/ -- China Biologic Products Holdings, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company in China , today announced its financial results for the fourth quarter and fiscal year of ...

The healthcare sector seems to be waking up over the past several weeks. Political uncertainty has been hurting healthcare stocks throughout the past year, but this uncertainty seems to be dissipating as the Presidential election approaches, which is being a major tailwind for the healthcare ...

China Biologic Products Holdings, Inc. (CBPO) Q3 2019 Results Conference Call November 14, 2019 07:30 AM ET Company Participants Sam Martin - Senior Account Executive Joseph Chow - Chairman and Chief Executive Officer Ming Yang - Chief Financial Officer Conference Call Partici...

The following slide deck was published by China Biologic Products Holdings, Inc. in conjunction with their 2019 Q3 earnings Read more ...

China Biologic Products (NASDAQ: CBPO ): Q3 Non-GAAP EPS of $1.40 beats by $0.52 ; GAAP EPS of $1.21. Revenue of $136.1M (+14.3% Y/Y) Press Release More news on: China Biologic Products Holdings, Inc., Earnings news and commentary, Healthcare stocks news,

BEIJING , Nov. 13, 2019 /PRNewswire/ -- China Biologic Products Holdings, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company in China , today announced its unaudited financial results for the third quarter of 201...

BEIJING , Nov. 4, 2019 /PRNewswire/ -- China Biologic Products Holdings, Inc. (NASDAQ: CBPO) ("China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company in China, today announced that the Company plans to release its third quarter 2019 finan...